Male Infertility Treatment Market By Techniques 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Male Infertility Treatment Market
Male Infertility Treatment Market: By Techniques (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, SPA, Sperm Agglutination, CASA),By Disorders (Idiopathic, varicocele, chryptrochidism, Obstructions, Testicular failure, Semen Disorders) & By Region-Forecast (2016-2021)
Report Code : HCR 0317
Updated Date: 26 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Male Infertility Treatment Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Male Infertility Treatment Market– Market Forces
   4.1. Drivers
      4.1.1. Increasing usage of fertilizers in developing economies
      4.1.2. Growing demand from pharmaceutical applications
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Male Infertility Treatment Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Male Infertility Treatment Market, By Techniques
   6.1. DNA Fragmentation Technique
   6.2. Oxidative Stress Analysis
   6.3. Microscopic Examination
   6.4. Sperm Penetration Assay
   6.5. Sperm Agglutination
   6.6. Computer Assisted Semen Analysis
7. Male Infertility Treatment Market, By Disorders
   7.1. Idiopathic
   7.2. Varicocele
   7.3. Chryptrochidism
   7.4. Obstructions
   7.5. Testicular failure
   7.6. Semen Disorders
   7.7. Others
8. Male Infertility Treatment Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Male Infertility Treatment – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. EMD Serona Inc.
   10.2. ASKA Pharmaceutical Co. Ltd
   10.3. Cordex Pharma, Inc.
   10.4. Access Pharmaceuticals, Inc.
   10.5. Pantarhei Biosciences
   10.6.  Merck Serono
   10.7. ZydusCadila Healthcare Limited
   10.8.  Halotech DNA SL
   10.9.  SCSA diagnostics
   10.10. Intas Pharmaceuticals Ltd.
   10.11. Andrology Solutions.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Male infertility can be defined as the inability to cause pregnancy in a fertile female by male counterpart. Generally male infertility is caused due to low sperm count, hormonal problem or presence of low number of motile sperms. Fertile male requires normal functioning of hypothalamus, pituitary gland, and testes. However some of the other common causes of increasing infertility in male includes consumption of alcohol and drugs, rising stress level, obesity, smoking, and environmental toxins. Globally increasing awareness and reducing shyness between people about disease is expected drive the demand for the male infertility treatment during the period of study.

 Male Infertility Treatment Market

Geographically North America dominated global Male Infertility Treatment market driven by best in the class healthcare infrastructure, advanced facilities and awareness and openness amongst citizens towards the disease. North America was followed by Europe and Asia-Pacific as second and third largest market  for male infertility treatment market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.

This report identifies the global Male Infertility Treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Male Infertility Treatment market.

This report segments global Male Infertility Treatment market on the basis of  techniques, disorders, and regional market as follows:
  • Male Infertility Treatment Market, By Technique: DNA Fragmentation Technique,Oxidative Stress Analysis, Microscopic Examination, Sperm Penetration Assay, Sperm Agglutination, Computer Assisted Semen Analysis
  • The report has focused study on Male Infertility Treatment market by basis of diorders such as: Idiopathic, Varicocele, Chryptrochidism, Obstructions, Testicular failure, Semen Disorders, Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Male Infertility Treatment market. Some of the major companies’ profiles in detail are as follows:
  • EMD Serona Inc.
  • ASKA Pharmaceutical Co. Ltd
  • Cordex Pharma, Inc.
  • Access Pharmaceuticals, Inc.
  • Pantarhei Biosciences
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports